Suchergebnisse - "Ruiz-Valderas, Rosa"

PubPharm (38)

1

Higher Activation in CD4(+) T Cells But Similar Viral Control Among HIV/Hepatitis C Virus-Coinfected Patients on a Simplification Monotherapy

enthalten in: AIDS research and human retroviruses | 2016

von BenMarzouk-Hidalgo, O. | Torres-Cornejo, A. | Gutierrez-Valencia, A. | +3

2

Higher Activation in CD4+ T Cells But Similar Viral Control Among HIV/Hepatitis C Virus-Coinfected Patients on a Simplification Monotherapy

enthalten in: Aids research and human retroviruses | 2016

von Torres-Cornejo, A. | Ruiz-Valderas, R. | López-Cortés, L. | +3

3

Does Once-Daily Raltegravir Have Any Role in the Antiretroviral Treatment?

enthalten in: Medicine | 2015

von Gutierrez-Valencia, A. | Chacón-Mora, N. | Ruiz-Valderas, R. | +4

4

Differential effects of viremia and microbial translocation on immune activation in HIV-infected patients throughout ritonavir-boosted darunavir monotherapy

enthalten in: Medicine | 2015

von BenMarzouk-Hidalgo, O. | Torres-Cornejo, A. | Gutiérrez-Valencia, A. | +3

5

Telaprevir and ribavirin interaction : higher ribavirin levels are not only due to renal dysfunction during triple therapy

enthalten in: Antimicrobial agents and chemotherapy | 2015

von Gutierrez-Valencia, A. | Ruiz-Valderas, R. | Ben-Marzouk-Hidalgo, O. | +5

6

Role of ritonavir in the drug interactions between telaprevir and ritonavir-boosted atazanavir

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2014

von Gutierrez-Valencia, A. | Ruiz-Valderas, R. | Torres-Cornejo, A. | +4

7

Cellular HIV reservoir replenishment is not affected by blip or intermittent viremia episodes during darunavir/ritonavir monotherapy

enthalten in: AIDS (London, England) | 2014

von Torres-Cornejo, A. | Benmarzouk-Hidalgo, O. | Gutiérrez-Valencia, A. | +5

8

Darunavir minimum plasma concentration and ritonavir-boosted darunavir monotherapy outcome in HIV-infected patients

enthalten in: Antiviral therapy | 2014

von Gutierrez-Valencia, A. | Torres-Cornejo, A. | BenMarzouk-Hidalgo, O. | +4

9

HCV viral decline at week 2 of Peg-IFN-alpha-2a/RBV therapy as a predictive tool for tailoring treatment in HIV/HCV genotype 1 co-infected patients

enthalten in: PloS one | 2014

von Rivero-Juarez, A. | López-Cortés, L. | Camacho, A. | +7

10

Lopinavir plasma concentrations and virological outcome with lopinavir-ritonavir monotherapy in HIV-1-infected patients

enthalten in: Antimicrobial agents and chemotherapy | 2013

von Lopez-Cortes, L. | Ruiz-Valderas, R. | Sánchez-Rivas, E. | +5